Michael D. Shmerling - 25 May 2023 Form 4 Insider Report for HEALTHSTREAM INC (HSTM)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
25 May 2023, 21:36:39 UTC
Prior SEC filing
21 Apr 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Michael D. Shmerling

Key filing fact

Michael D. Shmerling filed Form 4 for HEALTHSTREAM INC (HSTM) on 25 May 2023.

Key facts

  • This page summarizes Michael D. Shmerling's Form 4 filing for HEALTHSTREAM INC (HSTM).
  • 3 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 25 May 2023, 21:36.

Change

  • Previous filing in this sequence was filed on 21 Apr 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HSTM transaction

Common Stock Holding

Options Exercise

Transaction value
$0
Shares
+3,241
Change %
+2.5%
Price
$0.000000
Shares after
133,609
Date
25 May 2023
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HSTM transaction Derivative

Restricted Share Units

Options Exercise

Transaction value
$0
Shares
-944
Change %
-100%
Price
$0.000000*
Shares after
0
Date
25 May 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
944
Exercise price
$0.000000
Footnotes
F2, F3, F4
HSTM transaction Derivative

Restricted Share Units

Options Exercise

Transaction value
$0
Shares
-2,297
Change %
-100%
Price
$0.000000*
Shares after
0
Date
25 May 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,297
Exercise price
$0.000000
Footnotes
F2, F4, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Michael D. Shmerling is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 5 footnotes

Footnote F1

Shares acquired upon acceleration of the vesting of multiple grants of restricted share units ("RSUs") upon Mr. Shmerling's retirement from service on the Board of Directors ("Board") of HealthStream, Inc. (the "Company").

Footnote F2

Each RSU represents the contingent right to receive one share of common stock upon vesting of the unit.

Footnote F3

Reflects an amendment made to the terms of previously granted RSUs to provide for acceleration of the vesting of the unvested RSUs in connection with Mr. Shmerling's retirement from service on the Company's Board. These RSUs were initially subject to a three-year vesting schedule, contingent upon continued service at the time of vesting, and were originally scheduled to vest annually beginning March 17, 2022 in three equal installments. In connection with Mr. Shmerling's decision to retire from service on the Board effective concurrently with the Company's 2023 annual meeting of shareholders, the Company's Compensation Committee approved the accelerated vesting of all unvested RSUs to instead vest concurrent with his retirement as of the annual shareholder meeting date of May 25, 2023.

Footnote F4

Not applicable.

Footnote F5

Reflects an amendment made to the terms of previously granted RSUs to provide for acceleration of the vesting of the unvested RSUs in connection with Mr. Shmerling's retirement from service on the Company's Board. These RSUs were initially subject to a three-year vesting schedule, contingent upon continued service at the time of vesting, and were originally scheduled to vest annually beginning March 23, 2023 in three equal installments. In connection with Mr. Shmerling's decision to retire from service on the Board effective concurrently with the Company's 2023 annual meeting of shareholders, the Company's Compensation Committee approved the accelerated vesting of all unvested RSUs to instead vest concurrent with his retirement as of the annual shareholder meeting date of May 25, 2023.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .